{
  "data": [
    {
      "variable": "ONGOING TREATMENT",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "DEUC 6 mg N = 332"
    },
    {
      "variable": "ONGOING TREATMENT",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "PBO N = 333"
    },
    {
      "variable": "ONGOING TREATMENT",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Total N = 665"
    },
    {
      "variable": "COMPLETED TREATMENT",
      "stat": "309 ( 93.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "DEUC 6 mg N = 332"
    },
    {
      "variable": "COMPLETED TREATMENT",
      "stat": "306 ( 91.9)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "PBO N = 333"
    },
    {
      "variable": "COMPLETED TREATMENT",
      "stat": "615 ( 92.5)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Total N = 665"
    },
    {
      "variable": "DISCONTINUED TREATMENT",
      "stat": "23 ( 6.9)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "DEUC 6 mg N = 332"
    },
    {
      "variable": "DISCONTINUED TREATMENT",
      "stat": "27 ( 8.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "PBO N = 333"
    },
    {
      "variable": "DISCONTINUED TREATMENT",
      "stat": "50 ( 7.5)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Total N = 665"
    },
    {
      "variable": "LACK OF EFFICACY",
      "stat": "1 ( 0.3)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "DEUC 6 mg N = 332"
    },
    {
      "variable": "LACK OF EFFICACY",
      "stat": "2 ( 0.6)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "PBO N = 333"
    },
    {
      "variable": "LACK OF EFFICACY",
      "stat": "3 ( 0.5)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Total N = 665"
    },
    {
      "variable": "ADVERSE EVENT",
      "stat": "8 ( 2.4)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "DEUC 6 mg N = 332"
    },
    {
      "variable": "ADVERSE EVENT",
      "stat": "6 ( 1.8)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "PBO N = 333"
    },
    {
      "variable": "ADVERSE EVENT",
      "stat": "14 ( 2.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Total N = 665"
    },
    {
      "variable": "SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT",
      "stat": "2 ( 0.6)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "DEUC 6 mg N = 332"
    },
    {
      "variable": "SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT",
      "stat": "3 ( 0.9)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "PBO N = 333"
    },
    {
      "variable": "SUBJECT REQUEST TO DISCONTINUE STUDY TREATMENT",
      "stat": "5 ( 0.8)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Total N = 665"
    },
    {
      "variable": "SUBJECT WITHDREW CONSENT",
      "stat": "4 ( 1.2)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "DEUC 6 mg N = 332"
    },
    {
      "variable": "SUBJECT WITHDREW CONSENT",
      "stat": "10 ( 3.0)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "PBO N = 333"
    },
    {
      "variable": "SUBJECT WITHDREW CONSENT",
      "stat": "14 ( 2.1)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Total N = 665"
    },
    {
      "variable": "LOST TO FOLLOW-UP",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "DEUC 6 mg N = 332"
    },
    {
      "variable": "LOST TO FOLLOW-UP",
      "stat": "1 ( 0.3)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "PBO N = 333"
    },
    {
      "variable": "LOST TO FOLLOW-UP",
      "stat": "1 ( 0.2)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Total N = 665"
    },
    {
      "variable": "ADMINISTRATIVE REASONS BY SPONSOR",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "DEUC 6 mg N = 332"
    },
    {
      "variable": "ADMINISTRATIVE REASONS BY SPONSOR",
      "stat": "1 ( 0.3)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "PBO N = 333"
    },
    {
      "variable": "ADMINISTRATIVE REASONS BY SPONSOR",
      "stat": "1 ( 0.2)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Total N = 665"
    },
    {
      "variable": "OTHER",
      "stat": "8 ( 2.4)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "DEUC 6 mg N = 332"
    },
    {
      "variable": "OTHER",
      "stat": "4 ( 1.2)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "PBO N = 333"
    },
    {
      "variable": "OTHER",
      "stat": "12 ( 1.8)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Total N = 665"
    },
    {
      "variable": "DISCONTINUED TREATMENT DUE TO COVID-19",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "DEUC 6 mg N = 332"
    },
    {
      "variable": "DISCONTINUED TREATMENT DUE TO COVID-19",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "PBO N = 333"
    },
    {
      "variable": "DISCONTINUED TREATMENT DUE TO COVID-19",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Total N = 665"
    },
    {
      "variable": "ONGOING STUDY",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "DEUC 6 mg N = 332"
    },
    {
      "variable": "ONGOING STUDY",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "PBO N = 333"
    },
    {
      "variable": "ONGOING STUDY",
      "stat": "0",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Total N = 665"
    },
    {
      "variable": "DISCONTINUED STUDY",
      "stat": "22 ( 6.6)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "DEUC 6 mg N = 332"
    },
    {
      "variable": "DISCONTINUED STUDY",
      "stat": "23 ( 6.9)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "PBO N = 333"
    },
    {
      "variable": "DISCONTINUED STUDY",
      "stat": "45 ( 6.8)",
      "colgroup1": "colgroup1",
      "colgroup1_level": "Total N = 665"
    }
  ],
  "metadata": {
    "source_file": "rt-ds-trtwk16.rtf",
    "parser": "RTF row-based parser with hierarchical support",
    "timestamp": "2025-07-10 11:51:53",
    "title": "Table 14.1.1.4.1 Treatment Subject Status Summary Placebo-Controlled Treatment Period Treated Population",
    "footnotes": "Includes treated participants with at least one visit in the Placebo-Controlled Treatment Period. Percentages are based on a denominator of treated participants in each column with at least one visit in this period. Program Path: BMS_GBS Program Name: rt-ds-trtwk16.sas 12DEC2024:07:02:20"
  }
}
